Cancer Stem Cells Market, Size, Share, Outlook and Growth Opportunities 2019-2026

SKU: DHC12 | Last Updated On: Feb 24 2020 | No. of Pages: 205 | Available Formats

> Global Cancer Stem Cells Market Expected to reach a high CAGR of 6.7 % By 2026: DataM Intelligenceancer Therapy, Autologous SC Transplant, Allogeneic SC Transplant, Targeted Cancerous Stem Cells (CSCs)), By Anti-CSC Therapeutics, Surface Marker-based, Pathway Inhibitors, Nanoparticle-based Therapies, Others, by Products(Cell-Culturing, Cell Analysis, Molecular Analysis, Cell-Separation, Others), by region, and forecast to 2026

Global Cancer Stem Cells Market is segmented by Cancer Type( Blood Cancer, Breast Cancer, Colorectal Cancer, Lung Cancer, Liver Cancer, Brain Cancer, Others)by Mode of Action(Stem Cell-based Cancer Therapy, Autologous SC Transplant, Allogeneic SC Transplant, Targeted Cancerous Stem Cells (CSCs), By Anti-CSC Therapeutics, Surface Marker-based, Pathway Inhibitors, Nanoparticle-based Therapies, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2019-2026

 

Market Overview

The Cancer Stem Cells Market is expected to grow at a CAGR of 6.7% during the forecasting period (2019-2026).

  • Cancer Stem Cells' market growth is driven by several factors such as raising awareness about cancer stem cells leading to increase in the R&D for the development of operative and innovative treatment methods based on stem cells.

  • The cancer stem cells (CSCs) research studies are increasing which are helping healthcare professionals gain insights into CSCs biology and their signaling pathways.

  • However, stem cell-based cancer treatment is facing regulatory and ethical challenges which are restraining the growth of the market.
    Clinical Trial Analysis:
    Total Cancer Stem Cells Studies: 3342

  • Erivedge® (Roche) and Odomzo® (Novartis), two molecules that are commercially available in the market. About 50% of the product in the pipeline is still in the early preclinical stage. Nearly 49% of the pipeline molecules are under clinical development. Out of these,
    Phase III- 4 particles
    Phase II- 18 molecules
    Phase I/II- 18 fragments
    Phase I- 35 molecules

Regional Insights:

  • Geographically, the market is segmented into North America, South America, Europe, Asia-Pacific, and RoW. North America holds the largest market share in cancer stem cells market due to the availability of a high number of facilities in the U.S. offering stem cell services.

  • The Asia Pacific is expected to grow at the highest growth rate during the forecast period due to rising investments by various agencies to fast-track research activities in Asian countries.

  • Some of the major players in the global cancer stem cells market are:

  •  Thermo Fisher Scientific, Inc.

  •  AbbVie, Inc.

  •  Merck KGaA

  •  Bionomics

  •  Lonza.

What’s trending in this market?

Some recent developments in Cancer Stem Cells market are:

  • In Nov 2015, Merck introduced the new AldeRed ALDH Detection Kit for identifying and isolating cancer stem cells.
    The report covers the factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.

Who can benefit from this report?

  •  Raw Material Suppliers/ Buyers

  •  Product Suppliers/ Buyers

  •  Industry Investors/Investment Bankers

  •  Education & Research Institutes

  • Research Professionals

  •  Emerging Companies

  •  Manufacturers

Why should I purchase this report?

  •  Visualize the composition of the Global Cancer Stem Cells market across each indication, regarding type and applications, highlighting the critical commercial assets and players.

  •  Identify commercial opportunities in Global Cancer Stem Cells by analyzing trends and co-development deals.

  •  Excel data sheet with thousands of data points of the Global Cancer Stem Cells market – level 4/5 segmentation

  •  PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study

  •  Product mapping in excel for the key Global Cancer Stem Cells products of all major market players

 

Related Reports

Cancer Vaccines Market

 

 

 

Table of Content

1. Methodology and Scope

1.1 Research methodology

1.2 Scope of the Report

 

2. Executive Summary

3. Industry Analysis

3.1 Market Drivers

3.2 Market Restraints

3.3 Porters Five Forces Analysis

3.3.1 Suppliers Power

3.3.2 Buyer Power

3.3.3 Industry Competition

3.3.4 Threat of new Entrant

3.3.5 Threat of Substitutes

 

4. Product-based Analysis

4.1. Segmentation by Cancer Type

4.1.1 Blood Cancer

4.1.2 Breast Cancer

4.1.3 Colorectal Cancer

4.1.4 Lung Cancer

4.1.5 Liver Cancer

4.1.6 Brain Cancer

4.1.7 Others

4.2. Segmentation by Mode of Action

4.2.1 Stem Cell-based Cancer Therapy

4.2.1.1 Autologous SC Transplant

4.2.1.2 Allogeneic SC Transplant

4.2.2 Targeted Cancerous Stem Cells (CSCs)

4.2.2.1 By Anti-CSC Therapeutics

4.2.2.1.1 Surface Marker-based

4.2.2.1.2 Pathway Inhibitors

4.2.2.1.3 Nanoparticle-based Therapies

4.2.2.1.4 Others

4.2.2.2 Products

4.2.2.1.1 Cell-Culturing

4.2.2.1.2 Cell Analysis

4.2.2.1.3 Molecular Analysis

4.2.2.1.4 Cell-Separation

4.2.2.1.5 Others

 

5. Regional, Country-level Analysis

5.1. Asia Pacific

5.1.1. China

5.1.2. Japan

5.1.3. India

5.1.4. Australia

5.1.5. Rest of Asia Pacific

5.2. Europe

5.2.1. Germany

5.2.2. France

5.2.3. The UK

5.2.6. Rest of Europe

5.3. North America

5.3.1. The USA

5.3.2. Canada

5.3.3. Mexico

5.3.4. Rest of North America

5.4. South America

5.4.1. Brazil

5.4.2. Argentina

5.4.3. Rest of South America

5.5. RoW

6.  Epidemiology

 

7. Product Pipeline Analysis

 

8. Clinical Trial Analysis

 

9. Competitive Analysis

9.1 Market Share Analysis

9.2 Company Benchmarking

9.3 Key Strategies Adopted by Major Companies

 

10. Company Profiles

10.1 Merck KGaA

10.2 Thermo Fisher Scientific, Inc.

10.3 Bionomics.

10.4 AbbVie, Inc.

10.5 Stemline Therapeutics, Inc

10.6 LONZA

10.7 PromoCell GmbH

10.8 Miltenyi Biotec

10.9 STEMCELL Technologies Inc

10.10 BIOTIME, Inc

 

11. Appendix

11.1 Sources
11.2 List of Tables
11.3 Expert Panel Validation
11.4 Disclaimer
11.5 Contact Us
*Note: Additional company profiles will be included on request

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest